ALNYLAM PHARMACEUTICALS, INC.: operating_income

Value{"amount": -44070000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Period2010-01-01 – 2010-12-31
Statuscurrent
EntityALNYLAM PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950123-11-015737
Retrieved: 2026-08-19T11:51:48.525796+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001178670/operating-income/2010-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/0ce55d7c-d3d9-4248-bbc5-535f191081e7

History